表阿霉素为主化疗76例肿瘤病人心电图分析  

作　　者：郑悦海[1] 方红[1] 郑作深[1] 

机构地区：[1]中山大学附属江门医院/江门市中心医院,529070

出　　处：《当代医学》2010年第2期147-148,共2页Contemporary Medicine

摘　　要：目的探讨常规心电图对以表阿霉素为主化疗的肿瘤患者的心脏毒副作用的监控。方法对表阿霉素为主化疗肿瘤的76患者例化疗前、后常规12导联同步心电图进行对比分析。结果患者在表阿霉素化疗后,心电图改变的发生率为39.46%。结论常规心电图作为临床监控表阿霉素为主化疗所致的心脏毒副作用具有简便、实用的作用。Objective To investigate monitoring toxicity in the heart of cancer patients with the epirubicin-based chemotherapy by routine electrocardiogram.Methods 76 cancer patients,whom accepted epirubicin-based chemotherapy,were given routine 12-lead simultaneous ECG examination at the beginning,and the end of the chemotherapy,were analysed with the ECG changes Comparatively Results In the patients after epirubicin-based chemotherapy,the incidence of ECG changes rate is 39.46%.Conclusion ECG as a routine clinical monitoring for epirubicin-based chemotherapy induced cardiac toxicity is a simple and practical way.

关 键 词：心电图 表阿霉素 

分 类 号：R730.4[医药卫生—肿瘤]